share_log

B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29

B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29

Bof A Securities以買入評級啓動對Arrowhead Pharma的報道,宣佈目標股價爲29美元
Benzinga ·  2023/12/04 07:42

B of A Securities analyst Jason Gerberry initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $29.

Bof A Securities分析師傑森·格伯裏以買入評級開始對Arrowhead Pharma(納斯達克股票代碼:ARWR)進行報道,並宣佈目標股價爲29美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論